P2V Bioscience

P2V Bioscience is a biotechnology company based in Shrewsbury, Massachusetts, focused on the discovery and development of novel small molecule therapeutics. Founded by Dr. Sudhir Agrawal, the company leverages a proprietary 'Path-to-Value' (P2V) approach to target RNA and RNA-protein interactions. Their research primarily addresses high unmet needs in oncology and neurodegenerative diseases, such as ALS and Alzheimer's. P2V Bioscience aims to develop precision medicines by modulating RNA functions that were previously considered undruggable. The company is currently in the pre-clinical stage of development, utilizing its founder's extensive experience in nucleic acid-based drug discovery. By focusing on small molecules that can cross the blood-brain barrier, the company seeks to provide new treatment options for complex CNS disorders.